Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Endothelial cell anergy is mediated by bFGF through the sustained activation of p38-MAPK and NF-kappaB inhibition.

Flati V, Pastore LI, Griffioen AW, Satijn S, Toniato E, D'Alimonte I, Laglia E, Marchetti P, Gulino A, Martinotti S.

Int J Immunopathol Pharmacol. 2006 Oct-Dec;19(4):761-73.

PMID:
17166398
2.

Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy.

Thijssen VL, Postel R, Brandwijk RJ, Dings RP, Nesmelova I, Satijn S, Verhofstad N, Nakabeppu Y, Baum LG, Bakkers J, Mayo KH, Poirier F, Griffioen AW.

Proc Natl Acad Sci U S A. 2006 Oct 24;103(43):15975-80. Epub 2006 Oct 16.

3.

Angiogenic profile of breast carcinoma determines leukocyte infiltration.

Bouma-ter Steege JC, Baeten CI, Thijssen VL, Satijn SA, Verhoeven IC, Hillen HF, Wagstaff J, Griffioen AW.

Clin Cancer Res. 2004 Nov 1;10(21):7171-8.

4.

Isolation of human antibodies to tumor-associated endothelial cell markers by in vitro human endothelial cell selection with phage display libraries.

Mutuberria R, Satijn S, Huijbers A, Van Der Linden E, Lichtenbeld H, Chames P, Arends JW, Hoogenboom HR.

J Immunol Methods. 2004 Apr;287(1-2):31-47.

PMID:
15099754

Supplemental Content

Loading ...
Support Center